Top 20 Drugs of 2018 from Fierce Pharma


"Check out the list below, and you'll notice several major blockbusters benefiting from biosimilar delays. You'll also see some small-molecule meds that are about to fall hard to generic competition. Overall, the assortment of drugs spans specialty fields such as cancer and immunology, and mass-market indications such as diabetes." Fierce Pharma

Click on either image to go to article...


Featured Posts
Recent Posts